NCT07344116Not yet recruiting
Hepatobiliary and Pancreatic Tumor Biobank
Establishment of a Hepatobiliary and Pancreatic Tumor Biobank at a Single Academic Medical Center
Source: ClinicalTrials.gov · Last updated 15 Jan 2026
Brief summary (registry, in English)
This study aims to establish a hepatobiliary and pancreatic tumor biobank at the Second Affiliated Hospital of Zhejiang University School of Medicine. The biobank will systematically collect and store human biological samples, such as blood, tissue, bile, and other body fluids, together with relevant clinical and follow-up information from patients with hepatobiliary and pancreatic tumors, benign hepatobiliary and pancreatic diseases, and selected healthy volunteers. The collection of samples will be performed without changing routine medical care and will not involve any experimental treatment or additional invasive procedures for research purposes. Biological samples will be obtained during standard clinical diagnosis and treatment, or from remaining specimens after routine clinical use. All samples and data will be coded and stored according to ethical and legal requirements to protect participants' privacy. The biobank is intended to serve as a long-term research resource to support future basic, translational, and clinical research on hepatobiliary and pancreatic diseases, with the goal of improving understanding of disease mechanisms and advancing medical research in this field.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 7 Jan 2026
- Start date
- Jan 2026
- Primary completion date
- Dec 2036
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- NCT number
- NCT07344116
What you commit to
- Study type: Observational
- Planned participants: 300
- From Jan 2026 to the primary completion date, Dec 2036
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of conditions that, in the opinion of the investigators, make participation inappropriate or infeasible.
Age
- Age younger than 18 years.
Other
- Unable to provide informed consent and without a legally authorized representative.
- Refusal to allow the collection or use of biological specimens or clinical data for research.
Who the study is looking for
- Adults aged 18 years or older.
- Patients diagnosed with hepatobiliary or pancreatic malignant tumors, including but not limited to hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, and pancreatic cancer; or patients with benign hepatobiliary or pancreatic diseases; or selected healthy volunteers.
- Receiving medical care or health evaluation at the Second Affiliated Hospital of Zhejiang University School of Medicine.
- Able and willing to provide written informed consent, unless waived or exempted by the institutional ethics committee for retrospective samples.
- Willing to allow collection and storage of biological specimens and related clinical data for research purposes.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.